Literature DB >> 3707073

[Lithotripsy by ultrashort pulsation. Experimental study in renal lithiasis in the dog].

P Thibault, J Dory, J P Cotard, J Y Moraillon, G Vallancien, J André-Bougaran.   

Abstract

A lithotriptor delivering ultrashort shockwaves and designed for use under ultrasonographic guidance has recently been developed. Immersion in water is unnecessary. The device was experimented in renal lithiasis in dogs. Twenty-two animals were treated. In seven, who served as controls, the safety of shots delivered in particular to the lungs, liver, bones and kidneys was demonstrated. Furthermore, no cardiac rhythm disorders were recorded. A human stone was implanted in 15 animals. The stone was successfully broken up in 12. Gross and microscopic examinations done 2 to 30 days after the treatment indicate that the shots initially produce lesions similar to a limited contusion. Healing of the contusion, already underway on the 8th day, is complete by the 4th week. Elimination of the fragments is gradual. The quality of fragmentation can be evaluated during the treatment session using mode A ultrasonography. These experimental data are evidence of the effectiveness of this second generation lithotriptor.

Entities:  

Mesh:

Year:  1986        PMID: 3707073

Source DB:  PubMed          Journal:  Ann Urol (Paris)        ISSN: 0003-4401


  4 in total

Review 1.  ESWL '90--state of the art. Limitations and future trends of shock-wave lithotripsy.

Authors:  J Rassweiler; P Alken
Journal:  Urol Res       Date:  1990

Review 2.  ESWL and the future of stone management.

Authors:  F Eisenberger; A Schmidt
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

3.  Experiments with extracorporeal shock wave nephrolithotripsy.

Authors:  A A Li; N I Alekseyeva; L N Gerasimov
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 4.  Experimental basis of shockwave-induced renal trauma in the model of the canine kidney.

Authors:  J Rassweiler; K U Köhrmann; W Back; S Fröhner; M Raab; A Weber; F Kahmann; E Marlinghaus; K P Jünemann; P Alken
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.